Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


Articles published in Pediatr Infect Dis J

Retrieve available abstracts of 81 articles:
HTML format
Text format



Single Articles


    May 2017
  1. BASSAL R, Weil M, Cohen D, Sofer D, et al
    Seroprevalence of Hepatitis A 12-years Following the Implementation of Toddlers' Vaccination: A Population Based Study in Israel.
    Pediatr Infect Dis J. 2017 May 11. doi: 10.1097/INF.0000000000001640.
    PubMed     Text format     Abstract available


  2. SIRIMA SB, Tiono A, Gansane Z, Siribie M, et al
    Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study.
    Pediatr Infect Dis J. 2017;36:e136-e150.
    PubMed     Text format     Abstract available


  3. RIISE OR, Laake I, Vestrheim D, Flem E, et al
    Risk of Pertussis in Relation to Degree of Prematurity in Children Less Than 2 Years of Age.
    Pediatr Infect Dis J. 2017;36:e151-e156.
    PubMed     Text format     Abstract available


  4. HENAFF F, Levy C, Cohen R, Picard C, et al
    Risk Factors in Children Older Than 5 Years With Pneumococcal Meningitis: Data From a National Network.
    Pediatr Infect Dis J. 2017;36:457-461.
    PubMed     Text format     Abstract available


    April 2017
  5. DUBISCHAR KL, Kadlecek V, Sablan B Jr, Borja-Tabora CF, et al
    Safety of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO(R) in Children - an Open-Label, Randomized, Active-Controlled, Phase 3 Study.
    Pediatr Infect Dis J. 2017 Apr 24. doi: 10.1097/INF.0000000000001623.
    PubMed     Text format     Abstract available


  6. VAN DER LEE S, Kemmeren JM, de Rond LGH, Ozturk K, et al
    Elevated Immune Response Among Children 4 Years Of Age With Pronounced Local Adverse Events After The Fifth Dtap Vaccination.
    Pediatr Infect Dis J. 2017 Apr 19. doi: 10.1097/INF.0000000000001620.
    PubMed     Text format     Abstract available


  7. DUBISCHAR KL, Kadlecek V, Sablan B Jr, Borja-Tabora CF, et al
    Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO(R) n Children from a Japanese Encephalitis Virus -Endemic Region.
    Pediatr Infect Dis J. 2017 Apr 19. doi: 10.1097/INF.0000000000001615.
    PubMed     Text format     Abstract available


  8. OUTI V, Jukka J, Mika L, Tuija L, et al
    Rotavirus Vaccination and the Risk of Celiac Disease or Type 1 Diabetes in Finnish Children at Early Life.
    Pediatr Infect Dis J. 2017 Apr 10. doi: 10.1097/INF.0000000000001600.
    PubMed     Text format     Abstract available


  9. MAERTENS K, Burbidge P, Van Damme P, Goldblatt D, et al
    Pneumococcal Immune Response in Infants Whose Mothers Received Tdap Vaccination During Pregnancy.
    Pediatr Infect Dis J. 2017 Apr 10. doi: 10.1097/INF.0000000000001601.
    PubMed     Text format     Abstract available


  10. BRUIJNING-VERHAGEN P, Groome M
    Rotavirus Vaccine - Current Use and Future Considerations.
    Pediatr Infect Dis J. 2017 Apr 5. doi: 10.1097/INF.0000000000001594.
    PubMed     Text format    


    March 2017
  11. GOUVEIA M, Fiorentino F, Jesus G, Costa J, et al
    Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Portugal.
    Pediatr Infect Dis J. 2017 Mar 10. doi: 10.1097/INF.0000000000001587.
    PubMed     Text format     Abstract available


    February 2017
  12. SEDERDAHL BK, Yi J, Jerris R, Gillespie SE, et al
    The Residual Vaccine-Preventable Burden of Rotavirus Disease.
    Pediatr Infect Dis J. 2017 Feb 15. doi: 10.1097/INF.0000000000001580.
    PubMed     Text format     Abstract available


  13. LIVNI G, Wainstein A, Birk E, Chodick G, et al
    Influenza Vaccination Rate and Reasons for Non-Vaccination in Children with Cardiac Disease.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001579.
    PubMed     Text format     Abstract available


  14. CHRISTELLE TX, Min CS, Lee LY, Ong C, et al
    Serologic Responses After Hepatitis B Vaccination in Preterm Infants Born to Hepatitis B Surface Antigen Positive Mothers: Singapore Experience.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001578.
    PubMed     Text format     Abstract available


  15. LE MARECHAL M, Agrinier N, Fressard L, Verger P, et al
    Low Uptake of Meningococcal C Vaccination in France: A Cross-Sectional Nationwide Survey of General Practitioners' Perceptions, Attitudes and Practices.
    Pediatr Infect Dis J. 2017 Feb 3. doi: 10.1097/INF.0000000000001553.
    PubMed     Text format     Abstract available


    January 2017
  16. MARTINON-TORRES F, Dionne M, Greenberg D, Varman M, et al
    Safety, Tolerability, and Immunogenicity of Pentavalent Rotavirus Vaccine Manufactured by a Modified Process.
    Pediatr Infect Dis J. 2017 Jan 27. doi: 10.1097/INF.0000000000001511.
    PubMed     Text format     Abstract available


  17. PINTO M, Dawar M, Krajden M, Naus M, et al
    Will Infant Hepatitis B Vaccination Protect into Adulthood? Extended Canadian Experience After a 2, 4, 6 Month Immunization Schedule.
    Pediatr Infect Dis J. 2017 Jan 26. doi: 10.1097/INF.0000000000001543.
    PubMed     Text format     Abstract available


  18. CHUN CHAU JP, Lo SH, Chow Choi K, Kin Chau MH, et al
    Factors Determining the Uptake of Influenza Vaccination Among Children with Chronic Conditions.
    Pediatr Infect Dis J. 2017 Jan 19. doi: 10.1097/INF.0000000000001550.
    PubMed     Text format     Abstract available


  19. KUROSKY SK, Davis KL, Galindo CM
    Effect of Combination Vaccines on Hepatitis B Vaccine Compliance in Children in the United States.
    Pediatr Infect Dis J. 2017 Jan 17. doi: 10.1097/INF.0000000000001548.
    PubMed     Text format     Abstract available


  20. RODRIGUEZ MELO FI, Morales JJ, De Los Santos AH, Rivas E, et al
    Immunogenicity and Safety of a Booster Injection of DTap-IPV//Hib (Pentaxim(R)) Administered Concomitantly with Tetravalent Dengue Vaccine in Healthy Toddlers Aged 15 to 18 Months in Mexico: A Randomized Trial.
    Pediatr Infect Dis J. 2017 Jan 6. doi: 10.1097/INF.0000000000001542.
    PubMed     Text format     Abstract available


  21. LI F, Hu Y, Zhou Y, Chen L, et al
    A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.
    Pediatr Infect Dis J. 2017 Jan 3. doi: 10.1097/INF.0000000000001535.
    PubMed     Text format     Abstract available


    December 2016
  22. KOSALARAKSA P, Watanaveeradej V, Pancharoen C, Capeding MR, et al
    Long-Term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.
    Pediatr Infect Dis J. 2016 Dec 27. doi: 10.1097/INF.0000000000001494.
    PubMed     Text format     Abstract available


  23. SIRIMA SB, Tiono A, Gansane Z, Siribie M, et al
    Immunogenicity and Safety Of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children with Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study.
    Pediatr Infect Dis J. 2016 Dec 27. doi: 10.1097/INF.0000000000001518.
    PubMed     Text format     Abstract available


  24. DE WALS P, Zhou Z
    Cost-Effectiveness Comparison of Monovalent C Versus Quadrivalent ACWY Meningococcal Conjugate Vaccination in Canada.
    Pediatr Infect Dis J. 2016 Dec 23. doi: 10.1097/INF.0000000000001512.
    PubMed     Text format     Abstract available


  25. TRUCK J, Mitchell R, Jawad S, Clutterbuck EA, et al
    Divergent Memory B Cell Responses in a Mixed Infant Pneumococcal Conjugate Vaccine Schedule.
    Pediatr Infect Dis J. 2016 Dec 23. doi: 10.1097/INF.0000000000001497.
    PubMed     Text format     Abstract available


  26. MERINO ARRIBAS JM, Carmona Martinez A, Horn M, Porcuna XM, et al
    Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Co-Administered with Routine Childhood Vaccines in European Infants: An Open, Randomized Trial.
    Pediatr Infect Dis J. 2016 Dec 19. doi: 10.1097/INF.0000000000001484.
    PubMed     Text format     Abstract available


  27. MARCHISIO P, Esposito S, Picca M, Baggi E, et al
    Serotypes not Included in 13-Valent Pneumococcal Vaccine as Causes of Acute Otitis Media with Spontaneous Tympanic Membrane Perforation in a Geographic Area with High Vaccination Coverage.
    Pediatr Infect Dis J. 2016 Dec 15. doi: 10.1097/INF.0000000000001485.
    PubMed     Text format     Abstract available


  28. BECKER-DREPS S, Vilchez S, Bucardo F, Twitchell E, et al
    The Association Between Fecal Biomarkers of Environmental Enteropathy and Rotavirus Vaccine Response in Nicaraguan Infants.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  29. LEE AM, Burns JC, Tremoulet AH
    Safety of Infliximab Following Live Virus Vaccination in Kawasaki Disease Patients.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    November 2016
  30. MARTINON-TORRES F, Wysocki J, Center KJ, Czajka H, et al
    Circulating Antibody 1 and 2 Years After Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine in Preterm Compared with Term Infants.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  31. ZHANG L, Yang P, Thompson MG, Pan Y, et al
    Influenza Vaccine Effectiveness in Preventing Influenza Illness Among Children During School-Based Outbreaks in the 2014-2015 Season in Beijing, China.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  32. MAROM T, Peretz SB, Schwartz O, Goldfarb A, et al
    Impact of Pneumococcal Conjugate Vaccines on Selected Head and Neck Infections in Hospitalized Israeli Children.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  33. HARRIS SL, Donald RG, Hawkins JC, Tan C, et al
    Neisseria meningitidis Serogroup B Vaccine, Bivalent rLP2086, Induces Broad Serum Bactericidal Activity Against Diverse Invasive Disease Strains Including Outbreak Strains.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  34. SRICHAROENCHAI S, Lapphra K, Chuenkitmongkol S, Phongsamart W, et al
    Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination with Live Attenuated SA14-14-2 Vaccine: A Phase IV Study in Thai Children.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  35. BLOCK SL, Klein NP, Sarpong K, Russell S, et al
    Lot-to-Lot Consistency, Safety, Tolerability, and Immunogenicity of an Investigational Hexavalent Vaccine in US Infants.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  36. VESIKARI T, Becker T, Vertruyen AF, Poschet K, et al
    A Phase III Randomized, Double-Blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at 2, 3, 4, and 12 Months.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  37. AABY P, Ravn H, Benn CS
    The WHO Review of the Possible Nonspecific Effects of Diphtheria-Tetanus-Pertussis Vaccine.
    Pediatr Infect Dis J. 2016;35:1247-1257.
    PubMed     Text format     Abstract available


  38. MO X, Gai Tobe R, Liu X, Mori R, et al
    Cost-effectiveness and Health Benefits of Pediatric 23-valent Pneumococcal Polysaccharide Vaccine, 7-valent Pneumococcal Conjugate Vaccine and Forecasting 13-valent Pneumococcal Conjugate Vaccine in China.
    Pediatr Infect Dis J. 2016;35:e353-e361.
    PubMed     Text format     Abstract available


  39. BETTINGER JA, Vanderkooi OG, Scheifele DW, Halperin SA, et al
    Do Dose Numbers Matter?: Evaluation of Differing Infant and Toddler Meningococcal C Conjugate Vaccine Programs in Canadian Children.
    Pediatr Infect Dis J. 2016;35:1242-1246.
    PubMed     Text format     Abstract available


  40. AABY P, Ravn H, Benn CS, Rodrigues A, et al
    Randomized Trials Comparing Inactivated Vaccine After Medium- or High-titer Measles Vaccine With Standard Titer Measles Vaccine After Inactivated Vaccine: A Meta-analysis.
    Pediatr Infect Dis J. 2016;35:1232-1241.
    PubMed     Text format     Abstract available


  41. SMEDEGAARD LM, Poulsen A, Kristensen IA, Rosthoj S, et al
    Varicella Vaccination of Children With Leukemia Without Interruption of Maintenance Therapy: A Danish Experience.
    Pediatr Infect Dis J. 2016;35:e348-e352.
    PubMed     Text format     Abstract available


  42. ARYA BK, Bhattacharya SD, Sutcliffe CG, Kumar Niyogi S, et al
    Impact of Haemophilus influenzae Type B Conjugate Vaccines on Nasopharyngeal Carriage in HIV-infected Children and Their Parents From West Bengal, India.
    Pediatr Infect Dis J. 2016;35:e339-e347.
    PubMed     Text format     Abstract available


    October 2016
  43. SATTER S, Gastanaduy P, Islam K, Rahman M, et al
    Hospital-Based Surveillance for Rotavirus Gastroenteritis among Young Children in Bangladesh: Defining the Potential Impact of a Rotavirus Vaccine Program.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  44. GRUBER JF, Hille DA, Liu GF, Kaplan SS, et al
    Heterogeneity of Rotavirus Vaccine Efficacy among Infants in Developing Countries.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  45. MAMMEN VG, Dangor Z, Moore DP, Izu A, et al
    Hospitalization for Culture-Confirmed Pulmonary Tuberculosis in the Era of Childhood Pneumococcal Conjugate Vaccine Immunization.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  46. VESIKARI T, Silfverdal SA, Jordanov E, Feroldi E, et al
    A Randomized, Controlled Study of DTaP-IPV-HB-PRP-T, a Fully Liquid Hexavalent Vaccine, Administered in a 3, 5 and 11-12 Month Schedule.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  47. ZHU F, Deckx H, Roten R, Michiels B, et al
    Comparative Efficacy, Safety and Immunogenicity of Hepavax-Gene(R) TF and Engerix-B(R) Recombinant Hepatitis B Vaccines in Neonates in China.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  48. STRENG A, Grote V, Rack-Hoch A, Liese JG, et al
    Decline of Neurologic Varicella Complications in Children During the First 7 Years After Introduction of Universal Varicella Vaccination in Germany, 2005-2011.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  49. CIVEN R, Marin M, Zhang J, Abraham A, et al
    Update on Incidence of Herpes Zoster Among Children and Adolescents After Implementation of Varicella Vaccination, Antelope Valley, CA, 2000 to 2010.
    Pediatr Infect Dis J. 2016;35:1132-6.
    PubMed     Text format     Abstract available


    September 2016
  50. TOLEDO ME, Casanova MF, Linares-Perez N, Garcia-Rivera D, et al
    Prevalence of Pneumococcal Nasopharyngeal Carriage Among Children 2-18 Months of Age: Baseline Study Pre-Introduction of Pneumococcal Vaccination in Cuba.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  51. URUENA A, Gonzalez JE, Rearte A, Carrega ME, et al
    Single-Dose Universal Hepatitis A Immunization in One Year Old Children in Argentina: High Prevalence of Protective Antibodies Up to 9 Years Following Vaccination.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  52. WU D, Yen C, Yin ZD, Li YX, et al
    The Public Health Burden of Rotavirus Disease in Children <5 Years of Age and Considerations for Rotavirus Vaccine Introduction in China.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  53. PHILIP RK, Shapiro M, Paterson P, Glismann S, et al
    Is It Time For Vaccination To "Go Viral"?
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    August 2016
  54. KAUR R, Casey JR, Pichichero ME
    Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015.
    Pediatr Infect Dis J. 2016;35:901-6.
    PubMed     Text format     Abstract available


    July 2016
  55. HEMMING-HARLO M, Markkula J, Huhti L, Salminen M, et al
    Decrease of Rotavirus Gastroenteritis to a Low Level Without Resurgence for 5 Years After Universal RotaTeq(R) Vaccination in Finland.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  56. AABY P, Ravn H, Benn CS, Rodrigues A, et al
    Randomized Trials Comparing Inactivated Vaccine After Medium or High Titer Measles Vaccine with Standard Titer Measles Vaccine After Inactivated Vaccine: A Meta-Analysis.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  57. TAGARRO A, Bote P, Sanchez A, Otheo E, et al
    Complications of Pneumococcal Bacteremia After 13-Valent Conjugate Vaccine Withdrawal.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    June 2016
  58. MO X, Tobe RG, Liu X, Mori R, et al
    Cost-Effectiveness and Health Benefits of Pediatric 23-Valent Pneumococcal Polysaccharide Vaccine, 7-Valent and Forecasting 13-Valent Pneumococcal Conjugate Vaccines in China.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  59. AABY P, Ravn H, Benn CS
    The WHO Review of the Possible Non-Specific Effects of Diphtheria-Tetanus-Pertussis Vaccine.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  60. REGAN AK, de Klerk N, Moore HC, Omer SB, et al
    Effect of Maternal Influenza Vaccination on Hospitalization for Respiratory Infections in Newborns: A Retrospective Cohort Study.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  61. BETTINGER JA, Vanderkooi OG, Scheifele DW, Halperin SA, et al
    Do Dose Numbers Matter? Evaluation of Differing Infant and Toddler Meningococcal C Conjugate Vaccine Programs in Canadian Children.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  62. KITTIKRAISAK W, Suntarattiwong P, Ditsungnoen D, Klungthong C, et al
    Effectiveness of the 2013 and 2014 Southern Hemisphere Influenza Vaccines Against Laboratory-Confirmed Influenza in Young Children Using a Test-Negative Design, Bangkok, Thailand.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  63. WAGNER AL, Sun X, Huang Z, Ren J, et al
    On-Time Measles and Pneumococcal Vaccination of Shanghai Children: The Impact of Individual- and Neighborhood-Level Factors.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  64. SMEDEGAARD LM, Poulsen A, Kristensen IA, Rosthoj S, et al
    Varicella Vaccination of Children with Leukemia without Interruption of Maintenance Therapy - A Danish Experience.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  65. ARYA BK, Bhattacharya SD, Sutcliffe C, Niyogi SK, et al
    Impact of Haemophilus influenzae Type b Conjugate Vaccines (HibCV) on Nasopharyngeal Carriage in HIV Infected Children and Their Parents from West Bengal, India.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  66. OLBRICH P, Falcon-Neyra L, Molinos-Quintana A, Aguero-Sanchez M, et al
    First Documented Case of Influenza A (H3N2 Subtype) Infection in a Patient With Complete Interferon Gamma Receptor 1 Deficiency: A Call for Systemic Vaccination Strategies.
    Pediatr Infect Dis J. 2016;35:712-3.
    PubMed     Text format    


    May 2016
  67. KUTER BJ, Brown M, Wiedmann RT, Hartzel J, et al
    Safety and Immunogenicity of M-M-R(R)II (Combination Measles-Mumps-Rubella Vaccine) in Clinical Trials of Healthy Children Conducted Between 1988 and 2009.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  68. LOPEZ P, Lanata CF, Zambrano B, Cortes M, et al
    Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril(R)) when Administered Concomitantly with a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru: A Randomized Trial.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  69. LAMBERTI LM, Ashraf S, Walker CL, Black RE, et al
    A Systematic Review of the Effect of Rotavirus Vaccination on Diarrhea Outcomes Among Children Younger Than 5 Years.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  70. ZHU F, Hu Y, Li J, Ye Q, et al
    Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine Compared With 7-Valent Pneumococcal Conjugate Vaccine Among Healthy Infants in China.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  71. FINN A, Morales-Aza B, Sikora P, Giles J, et al
    Density Distribution of Pharyngeal Carriage of Meningococcus in Healthy Young Adults: New Approaches to Studying the Epidemiology of Colonization and Vaccine Indirect Effects.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  72. SHRIVASTWA N, Gillespie BW, Lepkowski JM, Boulton ML, et al
    Vaccination Timeliness in Children under India's Universal Immunization Program.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  73. DITKOWSKY J, Kohlhoff S, Smith-Norowitz TA
    The Cost-Effectiveness of Varicella Zoster Virus Vaccination Considering Late Onset Asthma.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  74. GRANT LR, Hammitt LL, O'Brien SE, Jacobs MR, et al
    Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage Among American Indians.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  75. WOO EJ, Winiecki SK, Arya D, Beeler J, et al
    Adverse Events After MMR or MMRV Vaccine in Infants Under 9 Months Old.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


  76. POYHONEN L, Pauniaho SL, Kroger L, Korppi M, et al
    Orthopedic Complications in Former Bacillus Calmette-Guerin Osteitis Patients.
    Pediatr Infect Dis J. 2016;35:579-80.
    PubMed     Text format     Abstract available


  77. GAENSBAUER JT, Asturias EJ, Soto M, Holt E, et al
    Pediatric Invasive Pneumococcal Disease in Guatemala City: Importance of Serotype 2.
    Pediatr Infect Dis J. 2016;35:e139-43.
    PubMed     Text format     Abstract available


    April 2016
  78. BRUUN T, Salamanca BV, Bekkevold T, Vainio K, et al
    Burden of Rotavirus Disease in Norway: Using National Registries for Public Health Research.
    Pediatr Infect Dis J. 2016;35:396-400.
    PubMed     Text format     Abstract available


  79. ALMEIDA AF, Flor-de-Lima F, Simoes JS, Castro C, et al
    Pertussis in a Portuguese Pediatric Tertiary Care Hospital.
    Pediatr Infect Dis J. 2016;35:466-7.
    PubMed     Text format    


  80. SHIN M, Salamanca BV, Kristiansen IS, Flem E, et al
    Healthcare Costs of Rotavirus and Other Types of Gastroenteritis in Children in Norway.
    Pediatr Infect Dis J. 2016;35:e97-e101.
    PubMed     Text format     Abstract available


    January 2016
  81. SNAPE MD, Voysey M, Biostat M, Finn A, et al
    Persistence of Bactericidal Antibodies Following Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: